Skip to main content
logo
Vietnam Medical and Pharmaceutical Investment JSC (HOSE:JVC)
Vietnam flag Vietnam · Delayed Price · Currency is VND
3,050.00
0.00 (0.00%)
At close: Aug 13, 2026

HOSE:JVC Cash Flow Statement

Millions VND. Fiscal year is Jan - Dec.

Operating Activities

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2017FY 2016
Period Ending
Jun '26 Dec '25 Jan '25 Jan '24 Mar '17 Mar '16
Net Income
50,78049,94540,28252,634-31,694-1,335,782
Depreciation & Amortization
23,98824,44135,30247,45469,64475,241
Other Amortization
423.63298.19--20.74-
Loss (Gain) From Sale of Assets
-8,201-16,588-24,512-25,9898,93128,695
Other Operating Activities
-2,6573,59121,1256,063-7,1861,282,007
Change in Accounts Receivable
121,149-178,98765,610-60,209-36,210-401,396
Change in Inventory
1,09330,244-95,9535,541108,86946,589
Change in Accounts Payable
70,678-2,73447,233-30,881-31,325-3,710
Change in Other Net Operating Assets
2,4441,244-3,333-1,088-4,922-10,667
Operating Cash Flow
259,699-88,54685,753-6,47476,126-319,023
Operating Cash Flow Growth
748.68%-----

Investing Activities

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2017FY 2016
Period Ending
Jun '26 Dec '25 Jan '25 Jan '24 Mar '17 Mar '16
Capital Expenditures
-20,451-41,862-16,594-43,363-42,587-8,810
Sale of Property, Plant & Equipment
-618.72,0013,93914,0493,0442,245
Investment in Securities
-411,460-302,800-140,000-752183,848
Other Investing Activities
10,68921,55117,33422,412171.14376.76
Investing Cash Flow
-191,851-101,062-267,211103,301-38,619177,660

Financing Activities

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2017FY 2016
Period Ending
Jun '26 Dec '25 Jan '25 Jan '24 Mar '17 Mar '16
Long-Term Debt Issued
-667,234262,560190,1952,500174,817
Total Debt Issued
716,306667,234262,560190,1952,500174,817
Long-Term Debt Repaid
--504,981-214,458-140,453-18,389-521,173
Total Debt Repaid
-705,947-504,981-214,458-140,453-18,389-521,173
Net Debt Issued (Repaid)
10,358162,25348,10249,742-15,889-346,356
Other Financing Activities
37,00037,000----
Financing Cash Flow
47,358199,25348,10249,742-15,889-346,356

Net Cash Flow

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2017FY 2016
Period Ending
Jun '26 Dec '25 Jan '25 Jan '24 Mar '17 Mar '16
Foreign Exchange Rate Adjustments
------0.07
Net Cash Flow
115,2069,646-133,355146,56921,618-487,720

Free Cash Flow

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2017FY 2016
Period Ending
Jun '26 Dec '25 Jan '25 Jan '24 Mar '17 Mar '16
Free Cash Flow
239,248-130,40869,159-49,83733,540-327,834
Free Cash Flow Growth
------
Free Cash Flow Margin
32.02%-17.09%11.31%-8.65%6.72%-64.62%
Free Cash Flow Per Share
2126.64-1159.18614.75-442.99298.13-2914.07
Levered Free Cash Flow
199,891-164,451-74,588-100,710199,243
Unlevered Free Cash Flow
214,120-155,275-71,190-103,584209,539

Additional Metrics

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2017FY 2016
Period Ending
Jun '26 Dec '25 Jan '25 Jan '24 Mar '17 Mar '16
Cash Interest Paid
23,17914,5335,4175,2124,76317,059
Cash Income Tax Paid
13,05216,2094,765-33,80529,761
Change in Working Capital
195,366-150,23313,556-86,63636,412-369,185